Sonex Health
Roy O'Hanley is an experienced sales professional with a strong background in the healthcare sector. Currently serving as Vice President of Sales and Training at Sonex Health since January 2019, Roy also holds the position of Director of U.S. Sales at NxThera since March 2015. Previously, Roy worked at Acclarent as Area Sales Director, managing ENT consultants and Regional Sales Managers to drive revenue growth. As General Manager (President/Owner) of Norman International, Roy successfully expanded revenue from $425,000 to $3 million over five years. Earlier career experience includes serving as Regional Sales Director at US Surgical, overseeing sales management and training in various regions. Roy O'Hanley earned a Bachelor's Degree in Business, Management, Marketing, and Related Support Services from Radford University.
This person is not in any offices
Sonex Health
Sonex Health reduces invasiveness, improves safety, and lowers the cost of care through transformative ultrasound.“Refined simplicity” is the guiding principle behind Sonex Health. To drive efforts and innovations that result in elegant, effective solutions to some of the healthcare system’s most pressing needs. Mayo Clinic physicians DarrylBarnes, MD and Jay Smith, MD, and business operations expert Aaron Keenan founded Sonex Health in 2014. Sonex Health has developed the SX-One MicroKnife(R) with Meerkat Technology™ to treat carpal tunnel syndrome in a novel fashion, termed Micro-invasive Carpal Tunnel Release. This innovation allows a procedure that once took place in an operating room to be safely and effectively performed in a surgery center or office setting, resulting in rapid patient recovery, improved cosmesis, and reduced costs.The ultra-low-profile SX-One MicroKnife with Meerkat Technology is an innovative surgical device that enables physicians to perform Micro-invasive Carpal Tunnel Release surgery through a single micro-incision under ultrasound guidance, or with a traditional mini-open incision without ultrasound guidance. The SX-One MicroKnife utilizes a micro-incision that’s up to five times smaller than the incision made during traditional CTR surgery—an incision so small, it can be closed with a small adhesive bandage or strip instead of sutures or stitches. The result is a low-trauma surgical environment that has been associated with a more rapid recovery. Immobilization is unnecessary so patients can begin rehabilitation and get back to their jobs and lives.